This track focuses on the latest developments in antiviral therapies and strategies aimed at combating viral infections. Researchers are invited to present innovative approaches and novel compounds that demonstrate efficacy against a range of viruses.

This session will explore cutting-edge technologies and methodologies in vaccine design and production. Topics may include mRNA vaccines, vector-based vaccines, and novel adjuvants that enhance immune responses.

This track examines the immune mechanisms activated during viral infections and their implications for disease progression. Presentations will cover cellular and humoral responses, as well as the role of immune evasion by viruses.

This session focuses on the molecular and cellular mechanisms underlying viral pathogenesis. Researchers are encouraged to discuss the interplay between viral factors and host responses that contribute to disease severity.

This track addresses the epidemiological trends and patterns of infectious diseases globally. Presentations will highlight surveillance data, outbreak investigations, and the impact of social determinants on disease spread.

This session invites discussions on clinical trials and studies evaluating the safety and efficacy of antiviral treatments. Researchers will share insights on patient outcomes and challenges faced in clinical settings.

This track focuses on public health interventions and strategies aimed at controlling viral outbreaks. Topics may include vaccination campaigns, contact tracing, and community engagement in outbreak response.

This session explores the application of immunotherapy in treating viral infections and enhancing host immunity. Presentations will cover monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines.

This track will delve into the assessment of vaccine safety profiles and their effectiveness in diverse populations. Researchers are encouraged to present findings from post-marketing surveillance and real-world studies.

This session addresses the challenges posed by emerging and re-emerging viral pathogens. Discussions will focus on preparedness strategies, rapid response frameworks, and lessons learned from recent outbreaks.

This track emphasizes the importance of international collaboration in addressing infectious diseases. Presentations will highlight successful partnerships, data sharing initiatives, and the role of global health organizations.